The association between plasma visfatin levels and ED

International Journal of Impotence Research

Volumn 27, Issue 4, 2015, Pages 157-160

  Karatas O F ^a   Yildirim, M E ^a   Celik, H T ^a   Badem, H ^b   Cavis M ^a   Cimentepe E ^a  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b Yuksek Ihtisas Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; CYTOKINE; GLUCOSE BLOOD LEVEL; LIPID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; TESTOSTERONE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; LETHAL DOSE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; BLOOD; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; OBESITY; YOUNG ADULT;

ADULT; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; HUMANS; LIPIDS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; RISK FACTORS; TESTOSTERONE; YOUNG ADULT;

EID: 84937164344     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2015.1     Document Type: Article

References (28)

1. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
2. Lauman EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res 1999; 11(Suppl 1): S60-S64.
3. Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50-56.
4. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
5. Romacho T, Sánchez-Ferrer CF, Peiró C. Visfatin/Nampt: an adipokine with cardiovascular impact. Mediators Inflamm 2013; 2013: 946427.
6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
7. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011; 60: 1917-1925.
8. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
9. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1997; 75: 191-236.
10. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43: 658-665.
11. Montorsi P, Montorsi F, Schulman C. Is erectile dysfunction the tip of the iceberg of a systemic vascular disorder? Eur Urol 2003; 22: 352-354.
12. Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010; 121: 1439-1446.
13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
14. Chudek J, Adamczak M, Nieszporek T, Wiecek A. The adipose tissue as an endocrine organ-a nephrologists' perspective. Contrib Nephrol 2006; 151: 70-90.
15. Bessa SS, Hamdy SM, El-Sheikh RG. Serum visfatin as a non-traditional biomarker of endothelial dysfunction in chronic kidney disease: an Egyptian study. Eur J Intern Med 2010; 21: 530-535.
16. Pepene CE. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome. Clin Endocrinol 2012; 76: 119-125.
17. Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295: 1485-1494.
18. Ryan JG, Gajraj J. Erectile dysfunction and its association with metabolic syndrome and endothelial function among patients with type 2 diabetes mellitus. J Diabetes Complications 2012; 26: 141-147.
19. Wierzbicki AS, Solomon H, Lumb PJ, Lyttle K, Lambert-Hammill M, Jackson G. Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. Atherosclerosis 2006; 185: 421-425.
20. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007; 49: 237-244.
21. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kB activation in endothelial cells. Biochim Biophys Acta 2008; 1783: 886-895.
22. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T et al. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 959-965.
23. Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G et al. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006; 27: 824-831.
24. Corona G, Maggi M. The role of testosterone in erectile dysfunction. Nat Rev Urol 2010; 7: 46-56.
25. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011; 8: 272-283.
26. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 2008; 5: 2454-2463.
27. Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 25-31.
28. Heidler S, Temml C, Broessner C, Mock K, Rauchenwald M, Madersbacher S et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007; 177: 651-654.